首页> 外国专利> FRAGMENTS OF NKp44 AND NKp46 FOR TARGETING VIRAL-INFECTED AND TUMOR CELLS

FRAGMENTS OF NKp44 AND NKp46 FOR TARGETING VIRAL-INFECTED AND TUMOR CELLS

机译:NKp44和NKp46片段用于靶向感染病毒和肿瘤细胞

摘要

The present invention relates generally to peptides derived from the natural cytotoxicity receptors on natural killer (NK) cells and to antibodies against peptide epitopes on these receptor. In particular, the present invention identifies an essential epitope in the proximal domain of NKp46 and NKp44 receptors present on NK cells, as a crucial element for the binding to viral-infected. The present invention provides peptides that are derived from the amino acid sequence of NKp46 receptor, capable of specific targeting of viral-infected cells and tumor cells and monoclonal antibodies which recognize a specific domain of NKp46. The present invention further provides hyperglycosylated peptides that are derived from the NKp44 receptor, capable of specific targeting of viral-infected cells.
机译:本发明一般涉及衍生自天然杀伤(NK)细胞上的天然细胞毒性受体的肽,并且涉及针对这些受体上的肽表位的抗体。特别地,本发明将NK细胞上存在的NKp46和NKp44受体的近端结构域中的必需表位鉴定为结合病毒感染的关键元件。本发明提供了衍生自NKp46受体的氨基酸序列的肽,其能够特异性地靶向病毒感染的细胞和肿瘤细胞以及识别NKp46的特定结构域的单克隆抗体。本发明进一步提供了衍生自NKp44受体的高糖基化肽,其能够特异性地靶向病毒感染的细胞。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号